These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


431 related items for PubMed ID: 11187864

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.
    Rubinger M, Lillicrap D, Rivard GE, Teitel J, Carcao M, Hensman C, Walker I, Association of Hemophilia Clinic Directors of Canada.
    Haemophilia; 2008 Mar; 14(2):281-6. PubMed ID: 18194308
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group.
    Goodeve AC, Williams I, Bray GL, Peake IR.
    Thromb Haemost; 2000 Jun; 83(6):844-8. PubMed ID: 10896236
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical evaluation of recombinant human factor VIII (BAY w 6240) in the treatment of hemophilia A.
    Fukui H, Yoshioka A, Shima M, Tanaka I, Koshihara K, Fukutake K, Fujimaki M.
    Int J Hematol; 1991 Oct; 54(5):419-27. PubMed ID: 1756252
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of a recombinant factor VIII produced from a human cell line (simoctocog alfa).
    Franchini M, Mannucci PM.
    Expert Opin Drug Saf; 2017 Mar; 16(3):405-410. PubMed ID: 28103444
    [Abstract] [Full Text] [Related]

  • 31. Recombinant factor VIII concentrates.
    Franchini M, Lippi G.
    Semin Thromb Hemost; 2010 Jul; 36(5):493-7. PubMed ID: 20632247
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up.
    Mauser-Bunschoten EP, Posthouwer D, Fischer K, van den Berg HM.
    Haemophilia; 2007 Nov; 13(6):697-700. PubMed ID: 17877729
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII.
    Gringeri A, Tagliaferri A, Tagariello G, Morfini M, Santagostino E, Mannucci P, ReFacto-AICE Study Group.
    Br J Haematol; 2004 Aug; 126(3):398-404. PubMed ID: 15257713
    [Abstract] [Full Text] [Related]

  • 37. Management of bleeding disorders: basic science.
    Ofosu FA, Santagostino E, Grancha S, Marco P.
    Haemophilia; 2012 May; 18 Suppl 2():8-14. PubMed ID: 22530574
    [Abstract] [Full Text] [Related]

  • 38. Von Willebrand factor-containing factor VIII concentrates and inhibitors in haemophilia A. A critical literature review.
    Franchini M, Lippi G.
    Thromb Haemost; 2010 Nov; 104(5):931-40. PubMed ID: 20838738
    [Abstract] [Full Text] [Related]

  • 39. Inhibitors in Severe Hemophilia A: 25-Year Experience in Slovakia.
    Batorova A, Jankovicova D, Morongova A, Bubanska E, Prigancova T, Horakova J, Machyniakova M, Cervenka J, Chandoga J, Böhmer D, Mistrik M.
    Semin Thromb Hemost; 2016 Jul; 42(5):550-62. PubMed ID: 27235830
    [Abstract] [Full Text] [Related]

  • 40. Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development.
    Mannucci PM, Shi Q, Bonanad S, Klamroth R.
    Haemophilia; 2014 Sep; 20 Suppl 6():2-16. PubMed ID: 24975700
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.